Company Profile

Tissue Testing Technologies LLC (AKA: T3LLC~T3 LLC)
Profile last edited on: 11/10/2017      CAGE: 7AC31      UEI: ZSY2J1RRALT5

Business Identifier: Development of cryopreservation methods to provide human cell-based in vitro systems for high throughput screening purposes
Year Founded
2014
First Award
2010
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2231 Technical Parkway Suite A
North Charleston, SC 29406
   (843) 514-6164
   N/A
   www.t3-tissuetestingtechnologies.com
Location: Single
Congr. District: 06
County: Charleston

Public Profile

Created by principles, and IP, of Cell and Tissue Systems, the primary focus of T3LLC is on low cost to market development of cryopreservation methods to provide human cell-based in vitro systems for high throughput screening purposes. T3 utilizes proprietary methods for preservation of human cell-derived monolayers and 3D cultures in multiwell plates. T3 is positioned to take advantage of the current trend away from animal testing for cosmetics, household chemicals and drugs by providing cryopreserved human cell-based tissue equivalents in place of current practice “just in time” manufacturing. The longer-term focus of T3LLC is research and development of ice-free cryopreservation methods for clinical applications. Such applications include major internal organs, larynx, trachea, abdominal wall, knee tissues, skeletal muscles, facial tissues and limb extremities, as well as critical natural and engineered tissues such as skin, heart valves and blood vessels. T3LLC also offers consulting and contract research services to commercial and academic organizations with an emphasis on living biological material transport and cryopreservation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Kevin G M Brockbank -- President; Chief Science Officer

  Lia H Campbell -- Research Director

  Taufiek Konrad Rajabi

Company News

There are no news available.